Home › Funds › Diametric Capital, LP › LQDA
Diametric Capital, LP position in LQDA
LIQUIDIA CORPORATION · Health Care
Diametric Capital, LP reported holding 105,781 shares of LQDA (LIQUIDIA CORPORATION) in its Q2 2026 13F filing — a position valued at US$8.4M, representing 0.94% of its reported portfolio and ranking #7 among its reported holdings. Diametric Capital, LP has disclosed LQDA holdings in 12 of the last 12 reported quarters, going back to Q3 2023.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Diametric Capital, LP's LQDA position evolved
Diametric Capital, LP first disclosed a stake in LQDA in Q3 2023 at 155,730 shares (US$987K). The position peaked in Q2 2026 at 105,781 shares, worth US$8.4M. Across 12 filings, Diametric Capital, LP increased the stake 6 time(s), trimmed it 5 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 105,781 shares valued at US$8.4M — a reduction of -61,979 shares quarter over quarter.. Notable position changes include a 69% trim in Q1 2024 (shares fell 19% over the following quarter), a 72% increase in Q2 2025 (shares rose 83% over the following quarter), a 83% increase in Q1 2026 (shares rose 111% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 155.73K | $987.33K | New |
| Q4 2023 | 222.21K | $2.67M | Add |
| Q1 2024 | 67.91K | $1.00M | Reduce |
| Q2 2024 | 83.33K | $999.96K | Add |
| Q3 2024 | 124.33K | $1.24M | Add |
| Q4 2024 | 132.03K | $1.55M | Add |
| Q1 2025 | 86.16K | $1.27M | Reduce |
| Q2 2025 | 148.60K | $1.85M | Add |
| Q3 2025 | 109.54K | $2.49M | Reduce |
| Q4 2025 | 91.49K | $3.16M | Reduce |
| Q1 2026 | 167.76K | $6.33M | Add |
| Q2 2026 | 105.78K | $8.43M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About LQDA and 13F data
LQDA (LIQUIDIA CORPORATION) is a Health Care company. 73 other funds we track also report a position in LQDA — the largest reported positions include Farallon Capital Management (US$666.9M), FARALLON CAPITAL MANAGEMENT, L.L.C. (US$666.9M), Caligan Partners LP (US$647.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding LQDA
- Farallon Capital Management 8.37M sh · $666.94M · Q2 2026
- FARALLON CAPITAL MANAGEMENT, L.L.C. 8.37M sh · $666.94M · Q2 2026
- Caligan Partners LP 8.12M sh · $647.32M · Q2 2026
- Opaleye Management Inc. 2.45M sh · $195.14M · Q2 2026
- Caprock Group, LLC 1.41M sh · $112.40M · Q2 2026
- MPM BioImpact LLC 1.39M sh · $110.52M · Q2 2026
- FINDELL CAPITAL MANAGEMENT LLC 1.30M sh · $103.66M · Q2 2026
- BOOTHBAY FUND MANAGEMENT, LLC 622.72K sh · $49.65M · Q2 2026
- Eversept Partners, LP 428.65K sh · $34.18M · Q2 2026
- Seven Fleet Capital Management LP 256.60K sh · $20.46M · Q2 2026
- Capricorn Fund Managers Ltd 182.21K sh · $14.53M · Q2 2026
- APIS CAPITAL ADVISORS, LLC 140.00K sh · $11.16M · Q2 2026
More on Diametric Capital, LP
FAQ
How long has Diametric Capital, LP held LQDA?
Diametric Capital, LP has disclosed LQDA holdings in 12 of the last 12 reported quarters, going back to Q3 2023.
What is Diametric Capital, LP's current position in LQDA?
As of Q2 2026, Diametric Capital, LP holds 105.78K shares of LQDA (LIQUIDIA CORPORATION), valued at $8.43M, representing 0.94% of its reported portfolio and ranking #7.
Has Diametric Capital, LP been buying or selling LQDA?
In the latest 13F filing (Q2 2026), Diametric Capital, LP reduced its position in LQDA. The position peaked in Q2 2026 at 105.78K shares.
Which other funds hold LQDA?
Other major institutional holders of LQDA include Farallon Capital Management, FARALLON CAPITAL MANAGEMENT, L.L.C., Caligan Partners LP, among 73 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.